Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa

Colleen M. Hadigan, B. Timothy Walsh, Catharine Buttinger, Eric Hollander

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

In response to the partial serotonin agonist meta-chlorophenylpiperazine (metaCPP), patients with obsessive-compulsive disorder have been reported to exhibit an increase in obsessive symptoms and a diminished release of prolactin and/or cortisol compared to controls. We examined the response to metaCPP of 10 patients with anorexia nervosa, before and after weight gain, and of eight healthy controls. Prior to weight gain, the patients exhibited a greater behavioral response to metaCPP than the controls and diminished prolactin and cortisol responses. Only the prolactin abnormality persisted after weight gain. These observations suggest that, in patients with anorexia nervosa, weight loss is associated with the development of neurobiological disturbances which are in some ways similar to those of obsessivecompulsive disorder.

Original languageEnglish (US)
Pages (from-to)504-511
Number of pages8
JournalBiological Psychiatry
Volume37
Issue number8
DOIs
StatePublished - Apr 15 1995
Externally publishedYes

Fingerprint

Anorexia Nervosa
Prolactin
Weight Gain
Hydrocortisone
Serotonin Receptor Agonists
Obsessive-Compulsive Disorder
Weight Loss
1-(3-chlorophenyl)piperazine

Keywords

  • Anorexia nervosa
  • cortisol
  • meta-chlorophenylpiperazine (metaCPP)
  • obsessive-compulsive disorder
  • prolactin

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. / Hadigan, Colleen M.; Walsh, B. Timothy; Buttinger, Catharine; Hollander, Eric.

In: Biological Psychiatry, Vol. 37, No. 8, 15.04.1995, p. 504-511.

Research output: Contribution to journalArticle

Hadigan, Colleen M. ; Walsh, B. Timothy ; Buttinger, Catharine ; Hollander, Eric. / Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. In: Biological Psychiatry. 1995 ; Vol. 37, No. 8. pp. 504-511.
@article{0e28c32585d441ecbf705931c5044a82,
title = "Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa",
abstract = "In response to the partial serotonin agonist meta-chlorophenylpiperazine (metaCPP), patients with obsessive-compulsive disorder have been reported to exhibit an increase in obsessive symptoms and a diminished release of prolactin and/or cortisol compared to controls. We examined the response to metaCPP of 10 patients with anorexia nervosa, before and after weight gain, and of eight healthy controls. Prior to weight gain, the patients exhibited a greater behavioral response to metaCPP than the controls and diminished prolactin and cortisol responses. Only the prolactin abnormality persisted after weight gain. These observations suggest that, in patients with anorexia nervosa, weight loss is associated with the development of neurobiological disturbances which are in some ways similar to those of obsessivecompulsive disorder.",
keywords = "Anorexia nervosa, cortisol, meta-chlorophenylpiperazine (metaCPP), obsessive-compulsive disorder, prolactin",
author = "Hadigan, {Colleen M.} and Walsh, {B. Timothy} and Catharine Buttinger and Eric Hollander",
year = "1995",
month = "4",
day = "15",
doi = "10.1016/0006-3223(94)00169-4",
language = "English (US)",
volume = "37",
pages = "504--511",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa

AU - Hadigan, Colleen M.

AU - Walsh, B. Timothy

AU - Buttinger, Catharine

AU - Hollander, Eric

PY - 1995/4/15

Y1 - 1995/4/15

N2 - In response to the partial serotonin agonist meta-chlorophenylpiperazine (metaCPP), patients with obsessive-compulsive disorder have been reported to exhibit an increase in obsessive symptoms and a diminished release of prolactin and/or cortisol compared to controls. We examined the response to metaCPP of 10 patients with anorexia nervosa, before and after weight gain, and of eight healthy controls. Prior to weight gain, the patients exhibited a greater behavioral response to metaCPP than the controls and diminished prolactin and cortisol responses. Only the prolactin abnormality persisted after weight gain. These observations suggest that, in patients with anorexia nervosa, weight loss is associated with the development of neurobiological disturbances which are in some ways similar to those of obsessivecompulsive disorder.

AB - In response to the partial serotonin agonist meta-chlorophenylpiperazine (metaCPP), patients with obsessive-compulsive disorder have been reported to exhibit an increase in obsessive symptoms and a diminished release of prolactin and/or cortisol compared to controls. We examined the response to metaCPP of 10 patients with anorexia nervosa, before and after weight gain, and of eight healthy controls. Prior to weight gain, the patients exhibited a greater behavioral response to metaCPP than the controls and diminished prolactin and cortisol responses. Only the prolactin abnormality persisted after weight gain. These observations suggest that, in patients with anorexia nervosa, weight loss is associated with the development of neurobiological disturbances which are in some ways similar to those of obsessivecompulsive disorder.

KW - Anorexia nervosa

KW - cortisol

KW - meta-chlorophenylpiperazine (metaCPP)

KW - obsessive-compulsive disorder

KW - prolactin

UR - http://www.scopus.com/inward/record.url?scp=0028955948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028955948&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(94)00169-4

DO - 10.1016/0006-3223(94)00169-4

M3 - Article

VL - 37

SP - 504

EP - 511

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 8

ER -